<http://schema.org/description>
"Covidien's (COV) first-quarter earnings rose 3.1% year over year to $1.00 per share and beat the Zacks Consensus Estimate by 6 cents."^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.zacks.com/stock/news/131032/can-covidien-cov-keep-the-earnings-streak-alive>